Research team of the Institute at the University of California, Davis, has developed a technique for using stem cells to provide a treatment target genetic abnormalities seen in concrete for the treatment playback Huntington's disease control, progressive is a hereditary brain disorder that is not cause movement, dementia and death. The findings, available online in the journal Molecular Cell Neuroscience , suggests that a promising approach may be to block the disease from advancing.
"For the first time, we were able to provide a suppression normally we have an RNA decrease the synthesis of huntingtin protein abnormalities markedly, the sequence of stem cells directly into nerve cells, "director of research and Jan A. See Also . Nolta, of UC University of California, Davis Institute for stem cell therapies and regeneration program of Senior Research Fellow Davis said. "Gene therapy breakthrough gives the family affected by this disease in our team has made in the hope that it may one day become a reality."
Huntington's disease is managed with drugs, that the current treatment for the reduction of physical, mental and behavioral victims that can not exist. Check out also pay day loan. Other experts, the best opportunity to stop the progression of the disease, I think that will reduce or eliminate the protein (HTT) mutant huntingtin found in nerve cells of those with disease and Nolta. Interference RNA ( RNAi of technology), it is very effective to reduce the HTT protein level, it will be used to reverse the symptoms of the disease in mouse models has been shown.
And "is figuring out how to achieve it in the human brain in an effective way sustainable, safe and our task using technology interference RNA", the laboratory that Nolta, he received funding from the recently was for Regenerative Medicine California Institute of Technology to develop RNAi delivery system, for Huntington's disease. "We are looking for ways to use human stem cells in order to create a production plant of RNAi in the brain."
Huntington's disease, affects more than one-quarter of the ten thousand Americans. The fault can be passed down the family, even if only one parent has the abnormal huntingtin gene. See Also blizzard payday loan . This disease is caused by mutations in the gene is composed of repeating building blocks of DNA that appears abnormally on chromosome 4. Known as huntingtin protein - - is made of building blocks pattern, usually, on the other hand is repeated until 28 times on the chromosome, repeat many will be the cause of the abnormal form of protein too . Huntingtin protein, causing a catastrophic progression of the disease, will be accumulated in the brain. See Also car title loan . If there is a repeat of more than 35, individuals are usually cause symptoms in middle age. Abnormal DNA pattern, the more rare form of the disease, occurs in young people when repeated more times. Check out also buckeye state credit union .
University of California at Davis research team showed for the first time that inhibition of RNA sequences to significantly reduce unnecessary protein synthesis from the mutant gene can be transferred directly from donor cells to target cells. Check out also published news upcoming news submit a new story groups food network store. If you want to transfer to the target RNA sequence to suppress their team, Nolta, we designed, mesenchymal stem cells derived from human bone marrow donor is not affected by a genetic (MSC). Over the past 20 years, Nolta and her colleagues, it is safe and effective vehicle has been shown to provide enzyme to other cells and proteins MSC. She said, and find that you can also MSC transfer RNA enough to offer great promise and is the discovery have not been reported before, to reduce the level of the mutant protein by more than 50 percent in the target cells in an amount, of diseases like molecules directly from cell to cell people. Check out also published news upcoming news submit a new story groups new york drug rehab.
To find a pursuit worth its own new treatments for disease, "Huntington, lessons we are learning, the development of new treatments for genetic diseases other with the need to reduce it with the development of protein excess not only can be applied to, according to the "Nolta, who received how to transfer recently who, a research grant of the transformation leading from the National Institutes of Health to study mesenchymal stem cells of the microRNA to cells of damaged tissue , can be used for that process to treat injury or illness, and how other factors. "We are also these techniques, we expect to be able to use to fight with other conditions or Parkinson's disease as well as form and amyotrophic lateral sclerosis of some of the (Lou Gehrig's disease) . "
Article "A study of mesenchymal stem cells of RNAi-mediated transfer of Huntington's disease affects the nerve cells for the reduction of huntingtin, "Now, Scott D. Olson was co-authored in the Texas Medical Center in Houston. Other authors now, the Amal Kambal Washington University, St. Louis, Kari Pollock with the Institute of the University of California, Davis, Gaela Marie Mitchell, Heather Stewart, Stefano Kalomoiris, Whitney Carey, Catherine for therapeutic regeneration, and Karen and pepper Nacey,. Funding for the study was provided by the California Institute for Regenerative Medicine and KJ team.
UC Davis is playing scientists and about 150, a major role in regenerative medicine a variety of tasks of stem cell-related research projects at the location of the campus of both the Sacramento and Davis. Research at the University of California, Davis for reproduction treatment, (CIRM) is a facility that is supported by the California Institute of Technology, opened in 2010 in the Sacramento campus regenerative medicine. This $ 62 million facility, has become a hub of the University of stem cell science. It is included, the largest academic GMP lab in Northern California with rooms and manufacturing state-of-the-art equipment for cell and gene therapy. UC Davis also has the Translational Human Embryonic Stem Cells joint partnership with the Institute of pediatric research facilities and the sharing of Davis Regenerative Medicine located north Shriners Hospital in California children. Complements the Clinical and Translational Science Center at the University of all of the programs and facilities, focus by turning the stem cell treatment.
You can find something interesting in the following sponsored links perhaps.